Overview
MRVI market data
Price History
MRVI price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.91 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.48 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -37.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.28 – $7.44 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.5B · P/B 3.91 · P/S 7.15.
Company News
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $6.5Benzinga · Aug 7, 2026, 2:09 PM
Maravai LifeSciences Affirms FY2026 Sales Guidance of $205.000M-$215.000M vs $210.433M EstBenzinga · Aug 6, 2026, 8:12 PM
Maravai LifeSciences Q2 Adj. EPS $(0.02) Beats $(0.04) Estimate, Sales $51.442M Beat $48.682M EstimateBenzinga · Aug 6, 2026, 8:05 PM
Maravai LifeSciences' TriLink BioTechnologies Obtains New Patent From The China National Intellectual Property Administration, Patent Number ZL 2025 1 1246578.XBenzinga · Jul 20, 2026, 8:05 PM
8-K filing — MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)SEC EDGAR · Jun 3, 2026, 12:31 PM